17 results
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
12 Feb 24
Regulation FD Disclosure
5:23pm
– Assessment days (shown only for Cohort 1 above) is repeated for each cohort per eye; intensity & contrast assessment, kinetic perimetry, functional … Counting Finger Hand Motion Optometry and Vision Science 2012:89(9), 1257-1264 Cohort 2 (3 patients, 3 eyes)
20 Light Perception (Intensity & Contrast
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
9 Nov 23
Regulation FD Disclosure
7:02am
) is repeated for each cohort per eye; intensity & contrast assessment, kine8c perimetry, func8onal MRI, etc. § Safety review conducted … ), 1257-1264 Cohort 2 (3 patients, 3 eyes)
17 Light Perception (Intensity & Contrast Assessment) Assessment: § Series of visual s8muli (a series
FWP
KPRX
Kiora Pharmaceuticals Inc
15 May 23
Free writing prospectus
5:18pm
- AEs, PK & labs ▪ Secondary - Assessment days (shown only for Cohort 1 above) is repeated for each cohort per eye; intensity & contrast assessment … Intensity & Contrast Light Perception Goldmann Perimetry Visual Field MLOM Suite of ‘functional’ tests fMRI Cortical Imaging Subjective Interviews
FWP
KPRX
Kiora Pharmaceuticals Inc
14 Jul 22
Free writing prospectus
5:14pm
Intensity (photons/cm 2 · sec) KIO - 301: Restore Vision in Daily - Life Regular Settings Molecule Sensitive to a Broad Spectrum of Intensity
8-K
EX-99.1
KPRX
Kiora Pharmaceuticals Inc
11 Jan 22
Regulation FD Disclosure
12:00am
Light Intensity (photons/cm 2 · sec) KIO - 301: Light Intensity and Wavelength Sci. Rep. 7, 45487 (2017), Banghart, Trauner et al (2008) Wavelength (nm
8-K
EX-99.1
0hkgxmpwtbkh
14 Sep 21
Regulation FD Disclosure
4:20pm
10-K
oupjy65wnnhsne 7ny
31 Mar 15
Annual report
12:00am
424B4
1pnn bg19llvzl7exo7j
13 Feb 15
Prospectus supplement with pricing info
12:00am
DRS/A
paho2h 6o
8 Jul 14
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next